- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 infection and ACE2 inhibition
Authors
Keywords
-
Journal
JOURNAL OF HYPERTENSION
Volume 39, Issue 8, Pages 1555-1558
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-07-02
DOI
10.1097/hjh.0000000000002859
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation
- (2021) Babak Nami et al. JOURNAL OF HYPERTENSION
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
- (2020) Yanxiao Han et al. ACS Nano
- Covid-19 infection and mortality: a physiologist’s perspective enlightening clinical features and plausible interventional strategies
- (2020) Zaid A. Abassi et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- COVID-19
- (2020) Paolo Verdecchia et al. HYPERTENSION
- Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
- (2020) Paolo Verdecchia et al. JOURNAL OF HYPERTENSION
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- (2020) Eskild Petersen et al. LANCET INFECTIOUS DISEASES
- Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
- (2020) Jinsung Yang et al. Nature Communications
- Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
- (2020) Amanat Ali et al. Scientific Reports
- Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective
- (2020) Indu Khatri et al. Frontiers in Immunology
- Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
- (2013) Keiji Kuba et al. CIRCULATION JOURNAL
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started